PLPP1 and ovarian carcinoma: The results showed that LPP1 expression is significantly downregulated in melanoma, sarcoma, leukemia, bladder, breast, colorectal, kidney, lung, and ovarian cancers, and it is upregulated in lymphoma, brain and central nervous system, and prostate cancers.